Posted by Michael Wonder on 24 Apr 2023
Health Canada approves new antibody drug to help prevent serious RSV in babies
22 April 2023 - Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Nirsevimab, also known by its brand name Beyfortus, was authorised on 19 April. It was developed by AstraZeneca and Sanofi.
